Seeking Alpha

LifeSci Advisors  

Andrew McDonald is a healthcare investment professional with expertise in identifying transformative medicines as well as in forecasting clinical trial, regulatory, and sales outcomes. Prior to co-founding LifeSci Advisors, Andrew most recently served as senior biotechnology analyst at Great Point Partners, a dedicated life science hedge fund. From 2004-2006, Andrew was Co-head of Healthcare Research and Biotechnology Analyst at ThinkEquity Partners, a boutique investment bank. Prior to entering the financial services industry, Andrew was a medicinal chemist at Cytokinetics from 2001-2004, where he discovered and developed a promising anti-cancer agent now in clinical trials. Andrew began his pharmaceutical career as a ...More

See Seeking Alpha's policy on anonymous authors.

  • Description: Other. Trading frequency: Daily
  • Interests: Stocks - long, Stocks - short
LifeSci Advisors LifeSci Advisors is a unique consultancy founded to provide comprehensive equity research, strategic counsel, customized marketing communications and investor relations services to our clients in the life-sciences. LifeSci Advisors also generates independent market research by leveraging our proprietary ...More
Currently, you have no book details. Click edit to add book details.
OPTR - I just posted a survey of physicians on their expected use of DIFICID on my website: Oct 13, 2011